People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genome Medical Holding Co | — | Healthtech | Series C | $90.0M | $606.2M | 2024 |
| C2i Genomics, Inc. | — | Biotechnology | Series C | $62.0M | $1.5B | 2021 |
Alex Parker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alex Parker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Shaun Rodriguez | 2 | 3 |
| Stephen Bloch | 1 | 15 |
| Robert Green | 1 | 8 |
| Eli Casdin | 1 | 6 |
| Russell Glass | 1 | 5 |
| Nicholas Naclerio | 1 | 5 |
| Jessica Zeaske | 1 | 5 |
| Randal Scott | 1 | 4 |
| Mark Sylvester | 1 | 3 |
| Lisa Alderson | 1 | 2 |
| Jill Davies | 1 | 2 |
| Randal W. Scott | 1 | 2 |
| Iana Dimkova | 1 | 2 |
| Tim Howe | 1 | 2 |
| Minh Merchant | 1 | 2 |
| Ezra Sofer | 1 | 2 |
| Robert C Green | 1 | 2 |
| Omri Amirav-Drori | 1 | 1 |
| Elizabeth Moreno | 1 | 1 |
| Kristin Ashcraft | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.